36 devices · GMDN 38297
Teletherapy radionuclide systems deliver high-energy radiation to targeted areas of the body to treat cancerous tumors. These systems use a stationary, shielded radionuclide source—typically cobalt-60—to generate a precise external beam, enabling controlled dose delivery to malignant tissues while minimizing exposure to surrounding healthy tissue.
These devices are typically regulated as high-risk medical technology due to their radiation output and clinical precision. They are often supplied as integrated systems, including a treatment head, gantry, collimator, patient table, and operator console, and may require specialized installation, maintenance, and operator training in radiation safety and oncology.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.